EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel and Simplified Score for Determining Treatment Eligibility for Patients with Chronic Hepatitis B

Tanawat Geeratragool iD, Pisit Tangkijvanich iD, Supot Nimanong, Siwaporn Chainuvati, Phunchai Charatcharoenwitthaya iD, Tawesak Tanwandee, Watcharasak Chotiyaputta

Viruses · 2023

DOI: 10.3390/v15030724 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Tanawat Geeratragool und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

International guidelines for hepatitis B infection (HBV) recommend initiating antiviral treatment based on viral replication with inflammation or fibrosis. HBV viral loads and liver fibrosis measurements are not widely available in resource-limited countries.

Aim

To develop a novel scoring system for the initiation of antiviral treatment in HBV-infected patients.

Methods

We examined 602 and 420 treatment-naïve, HBV mono-infected patients for derivation and validation cohorts. We performed regression analysis to identify parameters associated with the initiation of antiviral treatment based on the European Association for the Study of the Liver (EASL) guidelines. The novel score was developed based on these parameters.

Results

The novel score (HePAA) was based on HBeAg (hepatitis B e-antigen), the platelet count, alanine transaminase, and albumin. The HePAA score showed excellent performance, with AUROC values of 0.926 (95% CI, 0.901–0.950) for the derivation cohort and 0.872 (95% CI, 0.833–0.910) for the validation cohort. The optimal cutoff was ≥3 points (sensitivity, 84.9%; specificity, 92.6%). The HePAA score performed better than the World Health Organization (WHO) criteria and the Risk Estimation for HCC in Chronic Hepatitis B (REACH-B) score, and it performed similarly to the Treatment Eligibility in Africa for HBV (TREAT-B) score.

Conclusions

The HePAA scoring system is simple and accurate for chronic hepatitis B treatment eligibility in resource-limited countries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicCarcinoma, HepatocellularLiver NeoplasmsHumansAntiviral AgentsHepatitis B e AntigensAlanine TransaminaseHepatitis B virusDNA, Viral

Stichwörter der Autor:innen

Thailandhepatitis bscoresimplificationtreatment

Substanzen

Antiviral AgentsHepatitis B e AntigensAlanine TransaminaseDNA, Viral

Autor:innen und Institutionen

  • Division of Gastroenterology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
  • Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
  • Center of Excellence in Hepatitis and Liver Cancer, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.

ORCID-Profile: Tanawat Geeratragool, Pisit Tangkijvanich, Phunchai Charatcharoenwitthaya

Zitieren

APA

Geeratragool, T., Tangkijvanich, P., Nimanong, S., Chainuvati, S., Charatcharoenwitthaya, P., Tanwandee, T., & Chotiyaputta, W. (2023). A Novel and Simplified Score for Determining Treatment Eligibility for Patients with Chronic Hepatitis B. Viruses. https://doi.org/10.3390/v15030724

Vancouver

Geeratragool T, Tangkijvanich P, Nimanong S, Chainuvati S, Charatcharoenwitthaya P, Tanwandee T, et al. A Novel and Simplified Score for Determining Treatment Eligibility for Patients with Chronic Hepatitis B. Viruses. 2023. doi:10.3390/v15030724

BibTeX
@article{Geeratragool2023,
  author = {Geeratragool, Tanawat and Tangkijvanich, Pisit and Nimanong, Supot and Chainuvati, Siwaporn and Charatcharoenwitthaya, Phunchai and Tanwandee, Tawesak and Chotiyaputta, Watcharasak},
  title = {A Novel and Simplified Score for Determining Treatment Eligibility for Patients with Chronic Hepatitis B},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15030724}
}
Kostenlos starten →